Mutational analysis of
Coding exons
Oncogenic activation
Point mutations
Polymerase chain reaction - restriction fragment length polymorphism
Ras genes
Urothelial carcinoma of bladder
Journal
World journal of clinical oncology
ISSN: 2218-4333
Titre abrégé: World J Clin Oncol
Pays: United States
ID NLM: 101549149
Informations de publication
Date de publication:
24 Aug 2020
24 Aug 2020
Historique:
received:
20
01
2020
revised:
21
05
2020
accepted:
01
07
2020
entrez:
4
9
2020
pubmed:
4
9
2020
medline:
4
9
2020
Statut:
ppublish
Résumé
Mutational activation of To determine the presence/absence of mutations in This study was performed to determine the mutational spectrum at the hotspot regions of None of the 87 UCB patients showed point mutations in codon 12 of Our findings on the lack of mutations in
Sections du résumé
BACKGROUND
BACKGROUND
Mutational activation of
AIM
OBJECTIVE
To determine the presence/absence of mutations in
METHODS
METHODS
This study was performed to determine the mutational spectrum at the hotspot regions of
RESULTS
RESULTS
None of the 87 UCB patients showed point mutations in codon 12 of
CONCLUSION
CONCLUSIONS
Our findings on the lack of mutations in
Identifiants
pubmed: 32879848
doi: 10.5306/wjco.v11.i8.614
pmc: PMC7443835
doi:
Types de publication
Journal Article
Langues
eng
Pagination
614-628Informations de copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Références
Lancet. 1993 Aug 21;342(8869):469-71
pubmed: 8102431
PLoS One. 2010 Nov 03;5(11):e13821
pubmed: 21072204
Investig Clin Urol. 2020 Feb;61(Suppl 1):S8-S22
pubmed: 32055750
Tumori. 2007 Jan-Feb;93(1):4-12
pubmed: 17455864
Cancer Genet Cytogenet. 2000 Aug;121(1):73-7
pubmed: 10958945
J Natl Cancer Inst. 1995 Jan 18;87(2):129-33
pubmed: 7707384
Asian Pac J Cancer Prev. 2009;10(6):1063-6
pubmed: 20192584
J Urol. 2009 May;181(5):2312-9
pubmed: 19303097
Urol Int. 1995;55(2):63-7
pubmed: 8533197
Oncogene. 2005 Aug 4;24(33):5218-25
pubmed: 15897885
Urol J. 2008 Fall;5(4):237-42
pubmed: 19101897
J Cell Commun Signal. 2018 Sep;12(3):513-527
pubmed: 29330773
Front Genet. 2012 Jan 03;2:100
pubmed: 22303394
Hum Pathol. 1992 Nov;23(11):1199-204
pubmed: 1427748
Semin Cell Dev Biol. 2016 Oct;58:108-17
pubmed: 27338857
Nat Rev Drug Discov. 2014 Nov;13(11):828-51
pubmed: 25323927
Int J Oncol. 1992 Dec;1(7):731-4
pubmed: 21584608
Anticancer Res. 1998 Jul-Aug;18(4A):2675-8
pubmed: 9703927
Cancer Biomark. 2011-2012;10(6):259-66
pubmed: 22820081
Leukemia. 1989 Apr;3(4):247-56
pubmed: 2564452
J Biochem Mol Biol. 2003 Jul 31;36(4):399-402
pubmed: 12895299
Urol J. 2010 Summer;7(3):168-73
pubmed: 20845292
Urol Clin North Am. 2000 Feb;27(1):83-102, ix
pubmed: 10696248
PLoS One. 2019 Aug 1;14(8):e0220173
pubmed: 31369573
J Invest Dermatol. 1994 Mar;102(3):285-90
pubmed: 8120410
PLoS One. 2011 Apr 14;6(4):e18583
pubmed: 21533174
Environ Health. 2012 Jun 28;11 Suppl 1:S11
pubmed: 22759493
Oncol Rep. 2000 May-Jun;7(3):497-500
pubmed: 10767358
Biochem Biophys Res Commun. 2004 Nov 12;324(2):964-9
pubmed: 15474521
Cancer Metastasis Rev. 2015 Dec;34(4):691-701
pubmed: 26328525